Lysosomes, autophagosomes and Alzheimer pathology in dementia with Lewy body disease

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Rowan GurneyDavid M A Mann

Abstract

A failure of protein degradation may underpin Lewy body disease (LBD) where α-synuclein is assimilated into the pathognomic Lewy bodies and Lewy neurites. We investigated histological alterations in lysosomes and autophagosomes in the substantia nigra (SN) and cingulate gyrus (CG) in 34 patients with LBD employing antibodies against phosphorylated α-synuclein and lysosomal (lysosomal associated membrane proteins 1 and 2 (LAMP-1 and LAMP-2), cathepsin D (CTSD)) and autophagosomal (microtubule-associated protein light chain 3α (LC3A)) proteins. Immunostained sections were qualitatively and semi-quantitatively assessed for the appearance, distribution and intensity of staining. Four LBD patients had mutations in GBA1. There was significantly less LAMP-1, LAMP-2 and CTSD immunostaining in neurons of the SN in LBD cases compared to control cases and marginally less LAMP-1 in patients with GBA1 mutations compared to those without. Loss of LAMP-1 and CTSD immunoreactivity correlated with cell loss from the SN. There were no changes in LC3A immunoreactivity in the SN, nor any major changes in the CG, or glial cell activity in the SN and CG, for any of the markers. A proportion of amyloid plaques in both the LBD and control cases was im...Continue Reading

References

May 11, 1991·Lancet·P R WenhamG Blandell
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jul 1, 1966·The Journal of Clinical Investigation·R O BradyD Shapiro
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Oct 17, 1998·Nature·E LeroyM H Polymeropoulos
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Dec 31, 2002·Experimental Neurology·Kevin St P McNaughtC Warren Olanow
Dec 25, 2003·Lancet Neurology·Ian McKeithUNKNOWN International Psychogeriatric Association Expert Meeting on DLB
Sep 29, 2004·Lancet·Marie-Christine Chartier-HarlinAlain Destée
Oct 21, 2005·Neurology·I G McKeithUNKNOWN Consortium on DLB
Sep 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·C Warren Olanow, Kevin St P McNaught
Sep 16, 2006·Neuropathology and Applied Neurobiology·M BarrachinaI Ferrer
Sep 16, 2006·Molecular Aspects of Medicine·Eeva-Liisa Eskelinen
May 13, 2009·Archives of Neurology·Lorraine N ClarkKaren Marder
Oct 23, 2009·The New England Journal of Medicine·E SidranskyS G Ziegler
Nov 17, 2009·Nature Genetics·Javier Simón-SánchezThomas Gasser
Sep 17, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Benjamin DehayMiquel Vila
Oct 15, 2010·Nature Reviews. Molecular Cell Biology·Jens TyedmersBernd Bukau
Oct 23, 2010·Molecular Cell·Guido KroemerBeth Levine
Mar 18, 2011·Journal of Neuropathology and Experimental Neurology·Shinji HigashiEizo Iseki
Aug 3, 2011·Biotechnology and Bioengineering·Anirikh ChakrabartiJeffrey D Varner
Jul 4, 2012·Trends in Cell Biology·Susmita Kaushik, Ana Maria Cuervo
Jan 10, 2013·PloS One·Yoshihisa WatanabeMasaki Tanaka
Apr 17, 2013·JAMA Neurology·Michael A NallsEllen Sidransky
Nov 28, 2013·Cell Research·Ana Maria Cuervo, Esther Wong
Jan 31, 2014·Brain : a Journal of Neurology·Karen E MurphyGlenda M Halliday
Jan 13, 2015·Progress in Neurobiology·S Pablo SardiLamya S Shihabuddin
Jan 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Karen E MurphyGlenda M Halliday
Apr 27, 2016·Medicinal Research Reviews·Chiara VidoniCiro Isidoro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.